Status:
UNKNOWN
Receptor for Advanced Glycation End Products (RAGE) Polymorphisms In Inflammatory Bowel Disease
Lead Sponsor:
Assiut University
Conditions:
Inflammatory Bowel Diseases
Eligibility:
All Genders
Brief Summary
The inflammatory bowel diseases (IBD) are chronic inflammatory disorders of the gastrointestinal tract that manifests as Crohn's disease (CD) and Ulcerative colitis (UC . Over the last two decades the...
Detailed Description
This study aims: 1. To investigate the association of both allelic and genotypic -374T/A and -429T/C polymorphisms and inflammatory bowel disease. 2. To correlate the relation between the studied SNP...
Eligibility Criteria
Inclusion
- Egyprian IBD patients Attending ElRaghy Hospital in Assuit University hopital
- \-
Exclusion
- Exclusion criteria included the presence of neurological or cardiovascular diseases, diabetes, acute systemic illnesses, and previous or current history of cancer.
Key Trial Info
Start Date :
March 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2023
Estimated Enrollment :
180 Patients enrolled
Trial Details
Trial ID
NCT04286659
Start Date
March 1 2020
End Date
December 1 2023
Last Update
February 27 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.